Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.

Biasi F, Guina T, Maina M, Nano M, Falcone A, Aroasio E, Saracco GM, Papotti M, Leonarduzzi G, Poli G.

PLoS One. 2012;7(7):e41839. doi: 10.1371/journal.pone.0041839. Epub 2012 Jul 25.

2.

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS, Kim HJ, Kwon HC, Lee JH.

BMC Cancer. 2010 May 14;10:203. doi: 10.1186/1471-2407-10-203.

3.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
4.

Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.

Tahara K, Mimori K, Iinuma H, Iwatsuki M, Yokobori T, Ishii H, Anai H, Kitano S, Mori M.

Ann Surg Oncol. 2010 Dec;17(12):3362-9. doi: 10.1245/s10434-010-1149-2. Epub 2010 Jul 9.

PMID:
20617463
5.

[Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].

Li ZP, Han JQ, Meng XW, Yang YF.

Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):795-9. Chinese.

PMID:
21163075
6.

CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients.

Kamińska J, Kowalska MM, Nowacki MP, Chwaliński MG, Rysińska A, Fuksiewicz M.

Pathol Oncol Res. 2000;6(1):38-41.

7.

Clinical relevance of serum vascular endothelial growth factor and interleukin-6 in patients with colorectal cancer.

Eldesoky A, Shouma A, Mosaad Y, Elhawary A.

Saudi J Gastroenterol. 2011 May-Jun;17(3):170-3. doi: 10.4103/1319-3767.80378.

8.

Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.

Stompór T, Zdzienicka A, Motyka M, Dembińska-Kieć A, Davies SJ, Sulowicz W.

Perit Dial Int. 2002 Nov-Dec;22(6):670-6.

PMID:
12556068
9.

Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population.

Ognjanovic S, Yamamoto J, Saltzman B, Franke A, Ognjanovic M, Yokochi L, Vogt T, Decker R, Le Marchand L.

Cancer Causes Control. 2010 Jul;21(7):1131-8. doi: 10.1007/s10552-010-9540-7. Epub 2010 Mar 24.

PMID:
20333461
10.

Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.

Dragutinović VV, Radonjić NV, Petronijević ND, Tatić SB, Dimitrijević IB, Radovanović NS, Krivokapić ZV.

Mol Cell Biochem. 2011 Sep;355(1-2):173-8. doi: 10.1007/s11010-011-0851-0. Epub 2011 May 4.

PMID:
21541674
11.

[Inflammatory factors promote the development of colorectal cancer].

Guo Q, Shen S, Li X, Tang K, Zhou W.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Jul;36(7):646-9. doi: 10.3969/j.issn.1672-7347.2011.07.011. Chinese.

12.

Expression of matrix metalloproteinase-1 in human colorectal carcinoma.

Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I.

Mod Pathol. 2000 Sep;13(9):925-33.

13.
14.
15.

Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.

Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ.

Br J Cancer. 2011 Jan 4;104(1):51-9. doi: 10.1038/sj.bjc.6606005. Epub 2010 Nov 16.

16.

The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.

Tsamandas AC, Kardamakis D, Ravazoula P, Zolota V, Salakou S, Tepetes K, Kalogeropoulou C, Tsota I, Kourelis T, Makatsoris T, Karavias D, Scopa CD, Bonikos DS, Kalofonos HP, Petsas T.

Strahlenther Onkol. 2004 Apr;180(4):201-8.

PMID:
15057430
17.

Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.

Dong W, Li H, Zhang Y, Yang H, Guo M, Li L, Liu T.

Acta Biochim Biophys Sin (Shanghai). 2011 Nov;43(11):840-8. doi: 10.1093/abbs/gmr085. Epub 2011 Oct 3.

PMID:
21968416
18.
19.

Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.

Bellone G, Gramigni C, Vizio B, Mauri FA, Prati A, Solerio D, Dughera L, Ruffini E, Gasparri G, Camandona M.

Int J Oncol. 2010 Nov;37(5):1153-65.

PMID:
20878063
20.

Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.

Nakayama Y, Sako T, Shibao K, Onitsuka K, Nagashima N, Hirata K, Nagata N, Itoh H.

Anticancer Res. 2000 Nov-Dec;20(6A):4097-102.

PMID:
11131678

Supplemental Content

Support Center